CVRx (CVRX) Competitors $12.11 +0.39 (+3.33%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CVRX vs. BLFS, PLSE, AORT, EMBC, CBLL, LQDA, EYE, BVS, FNA, and AVNSShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), Liquidia (LQDA), National Vision (EYE), Bioventus (BVS), Paragon 28 (FNA), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. CVRx vs. BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia National Vision Bioventus Paragon 28 Avanos Medical CVRx (NASDAQ:CVRX) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, community ranking, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Do institutionals and insiders believe in CVRX or BLFS? 75.3% of CVRx shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 18.9% of CVRx shares are owned by insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, CVRX or BLFS? CVRx has higher earnings, but lower revenue than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$47.26M6.22-$41.20M-$2.70-4.49BioLife Solutions$146.96M8.65-$66.43M-$1.06-25.84 Does the media refer more to CVRX or BLFS? In the previous week, BioLife Solutions had 2 more articles in the media than CVRx. MarketBeat recorded 9 mentions for BioLife Solutions and 7 mentions for CVRx. CVRx's average media sentiment score of 1.09 beat BioLife Solutions' score of 0.45 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, CVRX or BLFS? CVRx has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Does the MarketBeat Community prefer CVRX or BLFS? BioLife Solutions received 282 more outperform votes than CVRx when rated by MarketBeat users. However, 70.00% of users gave CVRx an outperform vote while only 67.39% of users gave BioLife Solutions an outperform vote. CompanyUnderperformOutperformCVRxOutperform Votes2870.00% Underperform Votes1230.00% BioLife SolutionsOutperform Votes31067.39% Underperform Votes15032.61% Is CVRX or BLFS more profitable? BioLife Solutions has a net margin of -38.98% compared to CVRx's net margin of -123.75%. BioLife Solutions' return on equity of -6.61% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-123.75% -89.06% -52.56% BioLife Solutions -38.98%-6.61%-5.54% Do analysts prefer CVRX or BLFS? CVRx presently has a consensus target price of $16.67, suggesting a potential upside of 37.63%. BioLife Solutions has a consensus target price of $29.00, suggesting a potential upside of 5.88%. Given CVRx's higher probable upside, equities analysts plainly believe CVRx is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryBioLife Solutions beats CVRx on 12 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$293.84M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-4.4925.3789.9717.18Price / Sales6.2245.921,116.21116.99Price / CashN/A43.4542.8937.86Price / Book3.327.094.784.78Net Income-$41.20M$13.64M$120.23M$225.60M7 Day Performance-5.61%-2.93%-1.92%-1.23%1 Month Performance-17.48%0.28%11.49%3.36%1 Year Performance-52.19%40.76%30.57%16.60% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx3.7816 of 5 stars$12.11+3.3%$16.67+37.6%-49.2%$293.84M$47.26M-4.49200Positive NewsBLFSBioLife Solutions1.2666 of 5 stars$27.20+1.9%$28.29+4.0%+79.4%$1.26B$146.96M-25.19409Analyst ForecastInsider TradeNews CoveragePLSEPulse Biosciences1.8256 of 5 stars$20.50+16.1%N/A+56.3%$1.26B$700,000.000.00140Insider TradeNews CoverageAORTArtivion2.2159 of 5 stars$29.02+0.3%$31.80+9.6%+59.5%$1.22B$384.90M-1,446.501,500EMBCEmbecta3.7712 of 5 stars$19.84+1.7%$23.00+15.9%+13.5%$1.15B$1.12B14.712,200Short Interest ↓CBLLCeriBellN/A$29.04-0.6%$32.60+12.3%N/A$1.04B$60.04M0.00N/ALQDALiquidia3.4225 of 5 stars$11.07+1.4%$24.00+116.8%+3.7%$936.93M$15.61M-6.7050Analyst ForecastNews CoveragePositive NewsEYENational Vision3.0673 of 5 stars$11.59+1.6%$14.00+20.8%-41.2%$912.71M$2.13B-57.0513,998Analyst RevisionNews CoveragePositive NewsBVSBioventus3.6174 of 5 stars$11.17+1.3%$16.00+43.2%+104.8%$906.50M$555.06M-18.081,200Analyst UpgradeGap DownFNAParagon 283.0405 of 5 stars$10.60+1.7%$15.60+47.2%-17.7%$887.43M$245.00M-14.08343,000AVNSAvanos Medical3.4859 of 5 stars$17.88-0.5%N/A-27.4%$821.77M$673.30M52.853,771 Related Companies and Tools Related Companies BLFS Competitors PLSE Competitors AORT Competitors EMBC Competitors CBLL Competitors LQDA Competitors EYE Competitors BVS Competitors FNA Competitors AVNS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CVRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
